MJT & Associates Financial Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$63K Buy
730
+35
+5% +$3.08K 0.04% 66
2026
Q2
$54.4K Hold
695
– – 0.04% 78
2026
Q1
$60.2K Hold
695
– – 0.04% 73
2025
Q4
$66.8K Buy
695
+2
+0.3% +$194 0.05% 75
2025
Q3
$66K Sell
693
-14
-2% -$1.29K 0.05% 73
2025
Q2
$61.6K Hold
707
– – 0.08% 90
2025
Q1
$63.5K Buy
+707
New +$63.3K 0.06% 95

Other funds holding MDT

MJT & Associates Financial Advisory's MDT Position: Q3 2026 in Review

MJT & Associates Financial Advisory increased its Medtronic (MDT) stake by 5% in Q3 2026, buying an estimated $3.08K and bringing the position to 730 shares worth $63K. The position accounts for 0.04% of the portfolio, ranked #66.

MJT & Associates Financial Advisory first reported a position in MDT in Q1 2025 and has held it in 7 quarters since. The position peaked at $66.8K in Q4 2025. 119 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • MJT & Associates Financial Advisory held 730 shares of Medtronic worth $63K as of Q3 2026.
  • MJT & Associates Financial Advisory bought 35 Medtronic shares in Q3 2026, an estimated $3.08K.
  • Medtronic made up 0.04% of MJT & Associates Financial Advisory's portfolio in Q3 2026, its #66 holding.
  • MJT & Associates Financial Advisory first reported a position in Medtronic in Q1 2025 and has held it in 7 quarters since.
  • MJT & Associates Financial Advisory's Medtronic position peaked at $66.8K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q3 2026, filed 7 Oct 2026.